Diagonal Bio has initiated a collaboration with State Veterinary Institute (SVA) to evaluate testing for equine coronavirus in nasal swabs. The project is being carried out in October by a master's student from Swedish University of Agricultural Sciences (SLU) under the leadership of Johanna Lindahl, state veterinarian and professor. The study compares Diagonal Bios LAMPlifysystem with standard PCR tests to evaluate the effectiveness of coronavirus detection via nasal swabs.
|
Published October 3, 2025
Diagonal Bio collaborates with SVA for coronavirus testing
Notes
Sofinnova Partners raises EUR 650 million in new fund
Merck acquires Cidara for approximately USD 9,2 billion
Coegin Pharma launches first Follicopeptide product
Ascelia Pharma receives FDA acceptance for Orviglance application
Diamyd Medical passes safety review ahead of Phase III readout
Egetis reports positive results from the ReTRIACt study
Mikael Dolsten withdraws his nomination to Novo's board
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account